S. Duggirala

Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.

T. S. van der Werf, R. van Altena, S. Duggirala, 2011, Current pharmaceutical design.

FtsZ inhibition and redox modulation with one chemical scaffold: Potential use of dihydroquinolines against mycobacteria.

M. Doble, S. Duggirala, M. K. Manheri, 2016, European journal of medicinal chemistry.

Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.

K. Abass, T. S. van der Werf, Y. Stienstra, 2013, The American journal of tropical medicine and hygiene.

T-cell recognition of iron-regulated culture filtrate proteins of Mycobacterium tuberculosis in tuberculosis patients and endemic normal controls.

S. Duggirala, M. Sritharan, K. Subhakar, 2012, Indian journal of medical microbiology.

Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug

S. Duggirala, M. Sritharan, Veena C. Yeruva, 2006 .

Identification and Characterization of a Major Cell Wall-Associated Iron-Regulated Envelope Protein (Irep-28) in Mycobacterium tuberculosis

F. Altmann, D. Kolarich, S. Duggirala, 2006, Clinical and Vaccine Immunology.

Phytochemicals as Inhibitors of Bacterial Cell Division Protein FtsZ: Coumarins Are Promising Candidates

M. Doble, S. Rajendran, S. Duggirala, 2014, Applied Biochemistry and Biotechnology.

Multi-drug resistant tuberculosis in the Netherlands

S. Duggirala, R. Altena, Matthias I. P.Gröschel, 2016 .